234 related articles for article (PubMed ID: 18778751)
21. Cystitis-induced upregulation of tyrosine kinase (TrkA, TrkB) receptor expression and phosphorylation in rat micturition pathways.
Qiao LY; Vizzard MA
J Comp Neurol; 2002 Dec; 454(2):200-11. PubMed ID: 12412144
[TBL] [Abstract][Full Text] [Related]
22. Cannabinoid CB2 receptor activation inhibits mechanically evoked responses of wide dynamic range dorsal horn neurons in naïve rats and in rat models of inflammatory and neuropathic pain.
Elmes SJ; Jhaveri MD; Smart D; Kendall DA; Chapman V
Eur J Neurosci; 2004 Nov; 20(9):2311-20. PubMed ID: 15525273
[TBL] [Abstract][Full Text] [Related]
23. Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis.
Benito C; Romero JP; Tolón RM; Clemente D; Docagne F; Hillard CJ; Guaza C; Romero J
J Neurosci; 2007 Feb; 27(9):2396-402. PubMed ID: 17329437
[TBL] [Abstract][Full Text] [Related]
24. Antinociceptive effects of the non-selective cannabinoid receptor agonist CP 55,940 are absent in CB1(-/-) and not CB2(-/-) mice in models of acute and persistent pain.
Sain NM; Liang A; Kane SA; Urban MO
Neuropharmacology; 2009 Sep; 57(3):235-41. PubMed ID: 19538975
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of selective cannabinoid CB(1) and CB(2) receptor agonists in a mouse model of lipopolysaccharide-induced interstitial cystitis.
Tambaro S; Casu MA; Mastinu A; Lazzari P
Eur J Pharmacol; 2014 Apr; 729():67-74. PubMed ID: 24561047
[TBL] [Abstract][Full Text] [Related]
26. Expression and function of cannabinoid receptors CB1 and CB2 and their cognate cannabinoid ligands in murine embryonic stem cells.
Jiang S; Fu Y; Williams J; Wood J; Pandarinathan L; Avraham S; Makriyannis A; Avraham S; Avraham HK
PLoS One; 2007 Jul; 2(7):e641. PubMed ID: 17653268
[TBL] [Abstract][Full Text] [Related]
27. Spinal cord FAAH in normal micturition control and bladder overactivity in awake rats.
Füllhase C; Russo A; Castiglione F; Benigni F; Campeau L; Montorsi F; Gratzke C; Bettiga A; Stief C; Andersson KE; Hedlund P
J Urol; 2013 Jun; 189(6):2364-70. PubMed ID: 23219540
[TBL] [Abstract][Full Text] [Related]
28. Role of cannabinoid receptors in hepatic fibrosis and apoptosis associated with bile duct ligation in rats.
Mahmoud MF; Swefy SE; Hasan RA; Ibrahim A
Eur J Pharmacol; 2014 Nov; 742():118-24. PubMed ID: 25179573
[TBL] [Abstract][Full Text] [Related]
29. Cannabinoid receptors in conjunctival epithelium: identification and functional properties.
Iribarne M; Torbidoni V; Julián K; Prestifilippo JP; Sinha D; Rettori V; Berra A; Suburo AM
Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4535-44. PubMed ID: 18566465
[TBL] [Abstract][Full Text] [Related]
30. Increased expression of neuronal nitric oxide synthase in bladder afferent pathways following chronic bladder irritation.
Vizzard MA; Erdman SL; de Groat WC
J Comp Neurol; 1996 Jun; 370(2):191-202. PubMed ID: 8808730
[TBL] [Abstract][Full Text] [Related]
31. Cannabinoid CB
Spiller KJ; Bi GH; He Y; Galaj E; Gardner EL; Xi ZX
Br J Pharmacol; 2019 May; 176(9):1268-1281. PubMed ID: 30767215
[TBL] [Abstract][Full Text] [Related]
32. Increased expression of growth-associated protein (GAP-43) in lower urinary tract pathways following cyclophosphamide (CYP)-induced cystitis.
Vizzard MA; Boyle MM
Brain Res; 1999 Oct; 844(1-2):174-87. PubMed ID: 10536274
[TBL] [Abstract][Full Text] [Related]
33. Spinal neuronal cannabinoid receptors mediate urodynamic effects of systemic fatty acid amide hydrolase (FAAH) inhibition in rats.
Füllhase C; Schreiber A; Giese A; Schmidt M; Montorsi F; Gratzke C; La Croce G; Castiglione F; Stief C; Hedlund P
Neurourol Urodyn; 2016 Apr; 35(4):464-70. PubMed ID: 25788026
[TBL] [Abstract][Full Text] [Related]
34. CB2 cannabinoid receptor agonist selectively inhibits the mechanosensitivity of mucosal afferents in the guinea pig bladder.
Christie S; Zagorodnyuk V
Am J Physiol Renal Physiol; 2021 May; 320(5):F859-F865. PubMed ID: 33749323
[TBL] [Abstract][Full Text] [Related]
35. Effects of pro-inflammatory cytokines on cannabinoid CB1 and CB2 receptors in immune cells.
Jean-Gilles L; Braitch M; Latif ML; Aram J; Fahey AJ; Edwards LJ; Robins RA; Tanasescu R; Tighe PJ; Gran B; Showe LC; Alexander SP; Chapman V; Kendall DA; Constantinescu CS
Acta Physiol (Oxf); 2015 May; 214(1):63-74. PubMed ID: 25704169
[TBL] [Abstract][Full Text] [Related]
36. Role of CB1 and CB2 cannabinoid receptors in the development of joint pain induced by monosodium iodoacetate.
La Porta C; Bura SA; Aracil-Fernández A; Manzanares J; Maldonado R
Pain; 2013 Jan; 154(1):160-174. PubMed ID: 23199705
[TBL] [Abstract][Full Text] [Related]
37. Effects of Cannabinoid Agonists and Antagonists on Sleep and Breathing in Sprague-Dawley Rats.
Calik MW; Carley DW
Sleep; 2017 Sep; 40(9):. PubMed ID: 28934522
[TBL] [Abstract][Full Text] [Related]
38. Cellular localization and regulation of receptors and enzymes of the endocannabinoid system in intestinal and systemic inflammation.
Grill M; Hasenoehrl C; Kienzl M; Kargl J; Schicho R
Histochem Cell Biol; 2019 Jan; 151(1):5-20. PubMed ID: 30196316
[TBL] [Abstract][Full Text] [Related]
39. Cannabinoid receptor agonists upregulate and enhance serotonin 2A (5-HT(2A)) receptor activity via ERK1/2 signaling.
Franklin JM; Carrasco GA
Synapse; 2013 Mar; 67(3):145-59. PubMed ID: 23151877
[TBL] [Abstract][Full Text] [Related]
40. Modulation of Type-1 and Type-2 Cannabinoid Receptors by Saffron in a Rat Model of Retinal Neurodegeneration.
Maccarone R; Rapino C; Zerti D; di Tommaso M; Battista N; Di Marco S; Bisti S; Maccarrone M
PLoS One; 2016; 11(11):e0166827. PubMed ID: 27861558
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
